Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Baricitinib works better than methotrexate for severe alopecia areata.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

EGFR inhibitors can cause skin issues, but managing them is important for treatment success.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Dapagliflozin improved blood sugar control in a man with Werner syndrome without side effects.

Dutasteride may help shrink prostate cancer tumors.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Biological therapy boosts the immune system to effectively fight melanoma.

Upadacitinib may effectively treat resistant lichen planopilaris.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.